Figures & data
Table 1. ‘Ideal’ OAR constraints from the ILROG proton guidelines [Citation9].
Figure 1. Dose distribution of selected proton and photon plans for each case. The dose is shown as dose color wash from 50% to 110% as indicated by the scales shown to the left side. CTVs are shown as red contours and the beam angles are represented by the yellow lines.
![Figure 1. Dose distribution of selected proton and photon plans for each case. The dose is shown as dose color wash from 50% to 110% as indicated by the scales shown to the left side. CTVs are shown as red contours and the beam angles are represented by the yellow lines.](/cms/asset/2fd8ca4d-0fe1-49ae-b9cb-764caef11996/ionc_a_2251089_f0001_c.jpg)
Figure 2. Boxplots of dose to OARs for all proton and photon plans. The horizontal line represents the median, the boxes the interquartile range, and the whiskers the min/max values. OAR constraints are shown by the dotted horizontal lines. The breast mean dose (lower left corner) is shown for case B only, while the dose to the other OARs is shown for all cases (labelled A, B, and C). All metrics are statistically significantly different except lung V20Gy for patient B.
![Figure 2. Boxplots of dose to OARs for all proton and photon plans. The horizontal line represents the median, the boxes the interquartile range, and the whiskers the min/max values. OAR constraints are shown by the dotted horizontal lines. The breast mean dose (lower left corner) is shown for case B only, while the dose to the other OARs is shown for all cases (labelled A, B, and C). All metrics are statistically significantly different except lung V20Gy for patient B.](/cms/asset/5a1f5417-cd0f-4ff0-8bec-84660cf4d77e/ionc_a_2251089_f0002_b.jpg)
Data availability statement
The data that support the findings of this study are available from the corresponding author, upon reasonable request.